PRESS RELEASE published on 05/15/2023 at 07:00, 3 years 4 months ago Newron presents exciting new data from study 014/015 at CINP World Congress of Neuropsychopharmacology and the 2023 Congress of the Schizophrenia International Research Society (SIRS)
PRESS RELEASE published on 05/03/2023 at 07:00, 3 years 4 months ago Newron to present at the 34th CINP World Congress of Neuropsychopharmacology and the 2023 Congress of the Schizophrenia International Research Society (SIRS)
PRESS RELEASE published on 05/02/2023 at 07:00, 3 years 4 months ago Newron announces Senior Management Team changes
PRESS RELEASE published on 04/18/2023 at 12:15, 3 years 5 months ago Newron announces AGM 2023 results
PRESS RELEASE published on 03/28/2023 at 12:30, 3 years 6 months ago Newron presents six-month interim data from the first 100 patients randomized in study 014/015 at the 31st European Congress of Psychiatry
PRESS RELEASE published on 03/20/2023 at 07:00, 3 years 6 months ago Newron reports compelling topline results from all patients in Study 014, its Phase II clinical trial evaluating evenamide as add-on therapy for treatment-resistant schizophrenia
PRESS RELEASE published on 03/17/2023 at 07:00, 3 years 6 months ago Newron to present at the 31st European Congress of Psychiatry
PRESS RELEASE published on 03/14/2023 at 07:00, 3 years 6 months ago Newron announces 2022 financial results and provides outlook for 2023
PRESS RELEASE published on 02/16/2023 at 07:00, 3 years 7 months ago Newron reports striking one-year interim efficacy results from its Phase II clinical trial evaluating evenamide as add-on therapy for patients with treatment-resistant schizophrenia
PRESS RELEASE published on 01/03/2023 at 07:00, 3 years 8 months ago Newron announces striking six-month interim results from its exploratory clinical trial evaluating evenamide as add-on therapy for patients with treatment-resistant schizophrenia
Published on 09/29/2026 at 09:01, 1 hour 19 minutes ago Star Copper Advances Western Extension Drilling at Star Main
Published on 09/29/2026 at 06:45, 3 hours 35 minutes ago Akkodis and Biolevate Partner to Accelerate AI-Powered Scientific, Regulatory and Technical Documentation in Highly Regulated Industries
Published on 09/29/2026 at 04:36, 5 hours 44 minutes ago The Next Decade of Medical AI: How Humans and AI Collaborate - A Conversation Between Kevin Kelly and Dr. Ning Song of Diagens Tech (2526. HK)
Published on 09/29/2026 at 02:30, 7 hours 50 minutes ago QNX and neueHCT Join Forces to Accelerate Global Intelligent Driving Deployment, Anchored by Major German Automaker Program Win
Published on 09/29/2026 at 00:00, 10 hours 20 minutes ago Medicure Announces Completion of Enrollment in Its MEND-PNPO Phase 3 Clinical Trial
Published on 09/29/2026 at 10:00, 20 minutes ago Cyprumed‘s Oral Delivery Technology Advances to Clinical Stage as MSD Initiates Phase I Trial
Published on 09/29/2026 at 09:50, 29 minutes ago thyssenkrupp nucera Secures New Chlor-Alkali Order From Hongniu Lanzhou in China
Published on 09/29/2026 at 09:45, 35 minutes ago Beijing Chaoyang: A Sleepless City, A Stage for the World
Published on 09/29/2026 at 09:41, 39 minutes ago PNE Group once again sells a wind farm project in Poland to worldwide active energy utility
Published on 09/28/2026 at 17:54, 16 hours 25 minutes ago Reporting on share buyback transactions carried out between September 21 and September 25, 2026
Published on 09/28/2026 at 17:35, 16 hours 45 minutes ago Disclosure of transactions in own shares from September 21 to September 25, 2026
Published on 09/28/2026 at 08:02, 1 day 2 hours ago Saint-Gobain signs renewable electricity purchase agreement in the United Kingdom
